Login / Signup

Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label Trial.

Manjusha GaglaniSara S KimAllison L NalewayMin Z LevineLaura EdwardsKempapura MurthyKayan DunniganTnelda ZunieHolly GroomSarah BallZuha JeddyDanielle HuntMeredith G WesleySuryaprakash SambharaShivaprakash GangappaLauren GrantWeiping CaoF Liaini GrossMargarita MishinaAlicia M FryMark G ThompsonFatimah S DawoodBrendan Flannery
Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
In adult HCPs, receipt of RIV two consecutive seasons or the second season was more immunogenic than consecutive egg-based IIV for three of the four components of quadrivalent vaccine. Immunogenicity of ccIIV/ccIIV was similar to that of IIV/IIV. Differences in hemagglutinin antigen content may play a role in immunogenicity of influenza vaccination in consecutive seasons.
Keyphrases
  • open label
  • healthcare
  • phase iii
  • phase ii
  • clinical trial
  • study protocol
  • radiation therapy
  • phase ii study
  • social media
  • cell free
  • childhood cancer